(Q46351371)

21 December 2017

title

Dorothy Reed and Hodgkin's disease: a reflection after a century (English)

1 reference

21 December 2017

0 references

Matjaz Zwitter

1

1 reference

21 December 2017

Joel R Cohen

series ordinal

2

1 reference

21 December 2017

Ann Barrett

series ordinal

3

1 reference

21 December 2017

Elizabeth D Robinton

series ordinal

4

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

21 December 2017

International Journal of Radiation Oncology Biology Physics

published in

1 reference

21 December 2017

volume

53

1 reference

21 December 2017

issue

2

1 reference

21 December 2017

page(s)

366-375

1 reference

21 December 2017

Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Progressive transformation of germinal centers and nodular lymphocyte predominance Hodgkin's disease: a comparative immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Recent Results on the Biology of Hodgkin and Reed-Sternberg cells: II. Continuous Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Hodgkin's disease biology: recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Clonality and germinal centre B-cell derivation of Hodgkin/Reed-Sternberg cells in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Clonality of Reed-Sternberg cells in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Hodgkin's disease: biology and origin of Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

The molecular and cellular origins of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Childhood Social Environment and Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Characteristics in youth indicative of adult-onset Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

What causes Hodgkin's disease in children?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Socio-economic indicators, infectious diseases and hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Discrepancies in Epstein-Barr virus association at presentation and relapse of classical Hodgkin's disease: impact on pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Development of allergen-specific T-cell memory in atopic and normal children.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Postvaccinial lymphadenitis developing into Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Seasonal variation in the incidence of initial manifestations in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Infectious mononucleosis and Hodgkin's disease--a similar seasonality

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Hodgkin's disease: a tumor with disturbed immunological pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Immunology of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

The production of abnormal cells and Reed-Sternberg-like cells from normal lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

The antigen-presenting cell function of Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Regression of Hodgkin's disease after measles

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Cyclosporine may alleviate B symptoms and induce a remission of heavily pretreated Hodgkin disease: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Treatment selection for stage IIIA Hodgkin's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

The incidence of herpes zoster in patients with Hodgkin's disease. An analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Total lymphoid irradiation as an immunosuppressive agent for transplantation and the treatment of 'autoimmune' disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

The use of total lymphoid irradiation (TLI) as immunosuppressive therapy for organ allotransplantation and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

Total lymphoid irradiation for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902737-2

7 January 2021

10.1016/S0360-3016(02)02737-2

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017